EIDD-2749

Overview

EIDD-2749 (4'-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effectively blocks the replication of RSV and SARS-CoV-2 . EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus ( LCMV ). EIDD-2749 is a promising oral therapeutic candidate for COVID-19 and is also suitable for research on other RNA viruses.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Hepatitis C Virus Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > RSV | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > HCV

Product Information

• Catalog No.: HY-146246
• CAS No.: 1613589-24-4
• Molecular Formula: C9H11FN2O6
• Molecular Weight: 262.19
• Purity: 99.86%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 25 mg/mL (95.35 mM); Clear solution
• Availability: In-stock

Source

Original product source